Division of Renal Medicine, University of Cambridge, Cambridge, UK.
Nephrol Dial Transplant. 2013 Jun;28(6):1533-42. doi: 10.1093/ndt/gfs600. Epub 2013 Jan 17.
Gitelman syndrome (GS) is a rare inherited disorder caused by mutations in SLC12A3, encoding the thiazide-sensitive transporter NCCT (sodium chloride co-transporter) in the distal tubule. It is characterized by renal potassium (K) and magnesium (Mg) wasting, relative hypotension and hypocalciuria. However, there is phenotypic variability and long-term studies are scarce.
We retrospectively assessed clinical and genetic characteristics, and electrolyte requirements, in a cohort of 36 patients with genetically proven GS.
The 21 males and 15 females were of median age 39.5 years, range 17-66 years. Six were diagnosed in childhood. Among the 72 mutant alleles, 41 different sequence alterations were identified, of which 13 were previously unreported. Surprisingly, 44% (n = 16) of the cohort has developed hypertension (13 males, 3 females, P = 0.019; median age 53 versus 57 years, P = 0.95). One was already hypertensive by age 23 years. Currently normotensive patients were significantly younger: median 37 versus 55 years (P = 0.005). Hypertensive patients were more likely to harbour mutations in the C-terminal half of the NCCT protein (P = 0.016). Females required more K (median 128 versus 72 mmol/day; P = 0.01) but not Mg. Those with exon 26 and/or at least one destructive mutation had higher K requirements than those with neither: 108 versus 72 mmol (P = 0.016) and a tendency towards higher Mg needs: 30 versus 7.4 mmol (P = 0.07).
Our findings suggest that the development of secondary hypertension may be an expected feature of the ageing GS population despite the obligate salt wasting that characterizes the disorder. We hypothesize that this may be related to chronic secondary hyperaldosteronism. The apparently more severe phenotype in women may be related to the effects of female sex hormones on expression or function of NCCT.
Gitelman 综合征(GS)是一种罕见的遗传性疾病,由 SLC12A3 基因突变引起,该基因编码远曲小管中的噻嗪敏感转运体 NCCT(氯化钠共转运体)。其特征为肾性钾(K)和镁(Mg)丢失、相对低血压和低钙尿症。然而,该疾病存在表型异质性,且长期研究较为缺乏。
我们回顾性评估了 36 例经基因证实的 GS 患者的临床和遗传特征,以及电解质需求。
21 名男性和 15 名女性的中位年龄为 39.5 岁,范围为 17-66 岁。6 例在儿童期被诊断。在 72 个突变等位基因中,鉴定出 41 种不同的序列改变,其中 13 种为先前未报道过的。令人惊讶的是,44%(n=16)的患者出现了高血压(13 名男性,3 名女性,P=0.019;中位年龄 53 岁与 57 岁,P=0.95)。1 名患者在 23 岁时就已经患有高血压。目前血压正常的患者明显更年轻:中位年龄 37 岁与 55 岁(P=0.005)。高血压患者更有可能在 NCCT 蛋白的 C 末端发生突变(P=0.016)。女性需要更多的 K(中位 128 比 72 mmol/天;P=0.01),但不需要更多的 Mg。那些携带外显子 26 和/或至少一个破坏性突变的患者比既不携带也不携带的患者需要更高的 K:108 比 72 mmol(P=0.016),并且更倾向于需要更高的 Mg:30 比 7.4 mmol(P=0.07)。
我们的发现表明,尽管 GS 疾病的特征是强制性盐丢失,但继发性高血压的发展可能是 GS 老年人群的预期特征。我们假设这可能与慢性继发性醛固酮增多症有关。女性中明显更严重的表型可能与女性性激素对 NCCT 表达或功能的影响有关。